This website places cookies on your device to help us improve our service to you. To find out more, see our Privacy and Cookies statement.

Skip to page content


Scottish Immunisation Programme - Shingles Vaccination

Details of the 2017-18 Singles (Herpes Zoster) Vaccination Programme

Please refer to CMO Letter SGHD/CMO(2017) 13 dated 7th August 2017 at link below:

CMO Letter SGHD/CMO(2017)


On the 10th of July 2015 the Chief Medical Officer announced changes to the Scottish Immunisation Programme relating to the introduction of a vaccine for people aged 70 years (routine cohort) and 78 (catch up cohort) to protect against Shingles.  In order to support these changes NHS Education for Scotland in partnership with Health Protection Scotland has produced a number of resources for registered healthcare practitioners. 

Please note:  These educational resources continue to be updated as required to support this programme but do not replace the clinical judgement of practitioners. Practitioners should refer to the Public Health England Green Book Chapter when administering the vaccine.

Green Book Chapter 28B 

Details of the 2016-17 Shingles (Herpes Zoster) Vaccination Programme

The CMO letter in respect of the 2016/17 Shingles vaccination programme was published on 30th August 2016 and can be found at the link below:

CMO letter for the 2016/17 Shingles vaccination programme SGHD/CMO(2016)13 

Updated slides can be found below for the 2017/18 programme:

Slides (Office365 PowerPoint) - last reviewed February 2018

Slides (pdf) - last reviewed February 2018

Slides with notes pages(pdf) - last reviewed February 2018

Public Health England's healthcare professionals FAQs can be found at the following website:

Note: Please note the Public Health England FAQs resource reflects operational structures in England and practitioners in Scotland should refer in the first instance to the Health Protection Team in their local NHS Board.

Screening tool for contraindications for shingles vaccine

Shingles vaccine is a live attenuated vaccine and is therefore contraindicated for some patients groups.

  • A screening tool for contraindications for shingles vaccine has been produced by Health Protection Scotland and is available 
  • This tool may be used to aid identification of patients who are contra-indicated for this vaccine and includes explanatory notes for registered healthcare practitioners.
  • The questions in the screening tool are designed for completion either by the patient or by the registered healthcare practitioner in a structured interview with the patient

Please note: The screening tool is designed to help identify patients who may be contra-indicated for shingles vaccine and does not replace the clinical judgement of registered healthcare practitioners.


Full details are provided in Green Book Chapter on shingles (herpes zoster)